High EZH2 Protein Expression Is a Poor Prognostic Predictor in IDH1 R132H-Negative Gliomas.

Wong, Yin Ping; Che Abdul Aziz, Roziasyazni; Noor Aizuddin, Azimatun; Mohd Saleh, Muhamad Fakhri; Mohd Arshad, Roslina; Tan, Geok Chin

Wong, Yin Ping; Che Abdul Aziz, Roziasyazni; Noor Aizuddin, Azimatun; Mohd Saleh, Muhamad Fakhri; Mohd Arshad, Roslina; Tan, Geok Chin.

Afiliación

Wong YP; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Kuala Lumpur 56000, Malaysia.
Che Abdul Aziz R; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Kuala Lumpur 56000, Malaysia.
Noor Aizuddin A; Department of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Kuala Lumpur 56000, Malaysia.
Mohd Saleh MF; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Kuala Lumpur 56000, Malaysia.
Mohd Arshad R; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Kuala Lumpur 56000, Malaysia.
Tan GC; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Kuala Lumpur 56000, Malaysia.

Diagnostics (Basel) ; 12(10)2022 Sep 30.

Article en En | MEDLINE | ID: mdl-36292072

Palabras clave

EZH2; IDH1 R132H; glioma; immunohistochemistry; overall survival; prognosis; progression-free survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diagnostics (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Malasia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google